MiRNA-1 regulates endothelin-1 in diabetes

Life Sciences

Volumn 98, Issue 1, 2014, Pages 18-23

  Feng, Biao ^a   Cao, Yanan ^a,b   Chen, Shali ^a   Ruiz, Michael ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial cells; Glucose; MicroRNA

Indexed keywords

ENDOTHELIAL CELLS; GLUCOSE; MICRORNA;

ANIMALS; CELLS, CULTURED; DIABETES COMPLICATIONS; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIN-1; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; UMBILICAL VEINS;

EID: 84894416027     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.12.199     Document Type: Article

References (38)

1. J. Ai, R. Zhang, Y. Li, J. Pu, Y. Lu, and J. Jiao et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction Biochem Biophys Res Commun 391 2010 73 77
2. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
3. V. Chavali, S.C. Tyagi, and P.K. Mishra MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes Biochem Biophys Res Commun 425 2012 668 672
4. S. Chen, Z.A. Khan, M. Karmazyn, and S. Chakrabarti Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy Diabetes Metab Res Rev 23 2007 356 367
5. T.L. Cuellar, and M.T. McManus MicroRNAs and endocrine biology J Endocrinol 187 2005 327 332
6. A. Ergul Endothelin-1 and diabetic complications: focus on the vasculature Pharmacol Res 63 2011 477 482
7. B. Feng, and S. Chakrabarti miR-320 regulates glucose-induced gene expression in diabetes ISRN Endocrinol 2012 2012 549875
8. B. Feng, S. Chen, B. George, Q. Feng, and S. Chakrabarti miR133a regulates cardiomyocyte hypertrophy in diabetes Diabetes Metab Res Rev 26 2010 40 49
9. B. Feng, S. Chen, K. McArthur, Y. Wu, S. Sen, and Q. Ding et al. miR-146a-mediated extracellular matrix protein production in chronic diabetes complications Diabetes 60 2011 2975 2984
10. B. Feng, M.A. Ruiz, and S. Chakrabarti Oxidative-stress-induced epigenetic changes in chronic diabetic complications Can J Physiol Pharmacol 91 2013 213 220
11. S. Fichtlscherer, A.M. Zeiher, and S. Dimmeler Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31 2011 2383 2390
12. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ Res 107 2010 1058 1070
13. Y. Hashimoto, Y. Akiyama, and Y. Yuasa Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer PLoS One 8 2013 e62589
14. R.S. Hudson, M. Yi, D. Esposito, S.K. Watkins, A.A. Hurwitz, and H.G. Yfantis et al. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer Nucleic Acids Res 40 2012 3689 3703
15. I. Karakikes, A.H. Chaanine, S. Kang, B.N. Mukete, D. Jeong, and S. Zhang et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling J Am Heart Assoc 2 2013 e000078
16. M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, and J.J. Rossi et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via E-box repressors Proc Natl Acad Sci U S A 104 2007 3432 3437
17. H. Kaur, S. Chen, X. Xin, J. Chiu, Z.A. Khan, and S. Chakrabarti Diabetes-induced extracellular matrix protein expression is mediated by transcription co-activator p300 Diabetes 55 2006 3104 3111
18. Z.A. Khan, and S. Chakrabarti Cellular signaling and potential new treatment targets in diabetic retinopathy Exp Diabetes Res 2007 2007 31867
19. C. Kunsch, and R.M. Medford Oxidative stress as a regulator of gene expression in the vasculature Circ Res 85 1999 753 766
20. D. Li, P. Yang, H. Li, P. Cheng, L. Zhang, and D. Wei et al. MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1 Life Sci 91 2012 440 447
21. R. Madonna, and R. De Caterina Cellular and molecular mechanisms of vascular injury in diabetes - part I: pathways of vascular disease in diabetes Vascul Pharmacol 54 2011 68 74
22. T. Matsumoto, T. Kobayashi, and K. Kamata Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals J Smooth Muscle Res 44 2008 41 55
23. K. McArthur, B. Feng, Y. Wu, S. Chen, and S. Chakrabarti MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy Diabetes 60 2011 1314 1323
24. S. McGinn, P. Poronnik, M. King, E.D. Gallery, and C.A. Pollock High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity Am J Physiol Cell Physiol 284 2003 C1374 C1386
25. R. Natarajan, S. Putta, and M. Kato MicroRNAs and diabetic complications J Cardiovasc Transl Res 5 2012 413 422
26. D. Onat, D. Brillon, P.C. Colombo, and A.M. Schmidt Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis Curr Diab Rep 11 2011 193 202
27. C. Peng, J. Ma, X. Gao, P. Tian, W. Li, and L. Zhang High glucose induced oxidative stress and apoptosis in cardiac microvascular endothelial cells are regulated by FoxO3a PLoS One 8 2013 e79739
28. S. Putta, L. Lanting, G. Sun, G. Lawson, M. Kato, and R. Natarajan Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy J Am Soc Nephrol 23 2012 458 469
29. S.D. Rege, T. \Geetha, S.R. Pondugula, C.A. Zizza, C.M. Wernette, and J.R. Babu Noncoding RNAs in neurodegenerative diseases ISRN Neurol 2013 2013 375852
30. S.K. Sagar, C. Zhang, Q. Guo, R. Yi, and Lin-Tang Role of expression of endothelin-1 and angiotensin-II and hypoxia-inducible factor-1α in the kidney tissues of patients with diabetic nephropathy Saudi J Kidney Dis Transpl 24 2013 959 964
31. Z.X. Shan, Q.X. Lin, C.Y. Deng, J.N. Zhu, L.P. Mai, and J.L. Liu et al. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes FEBS Lett 584 2010 3592 3600
32. X. Shen, and K.E. Bornfeldt Mouse models for studies of cardiovascular complications of type 1 diabetes Ann N Y Acad Sci 1103 2007 202 217
33. P. Soon, and H. Kiaris MicroRNAs in the tumour microenvironment: big role for small players Endocr Relat Cancer 20 2013 R257 R267
34. G.H. Tesch, and T.J. Allen Rodent models of streptozotocin-induced diabetic nephropathy Nephrology (Carlton) 12 2007 261 266
35. T. Tien, K.F. Barrette, A. Chronopoulos, and S. Roy Effects of high glucose-induced Cx43 downregulation on occludin and ZO-1 expression and tight junction barrier function in retinal endothelial cells Invest Ophthalmol Vis Sci 54 10 2013 6518 6525 [Oct 3]
36. D.W. Thomson, C.P. Bracken, and G.J. Goodall Experimental strategies for microRNA target identification Nucleic Acids Res 39 2011 6845 6853
37. I.S. Vlachos, and A.G. Hatzigeorgiou Online resources for miRNA analysis Clin Biochem 46 2013 879 900
38. S.S. Yildirim, D. Akman, D. Catalucci, and B. Turan Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1 Cell Biochem Biophys 67 2013 1397 1408